Tag Archives: NASIADs

Celecoxib and Cardiovascular Disease

The New England Journal of Medicine has a paper in its current issue (Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis) that examines the safety of the COX-2 inhibitor celecoxib, best known under its brand name Celebrex, though now available in a generic formulation. This drug is the only COX-2 inhibitor available in the…

Read the full entry